Plasma cell-free DNA levels in children on peritoneal dialysis

O Ozkaya1, K Bek, A Bedir

  • 1Department of Pediatric Nephrology, Ondokuz Mayis University, School of Medicine, Samsun, Turkey. ozanozkaya@yahoo.com

Insights

Children undergoing peritoneal dialysis (PD) show elevated cell-free DNA (cfDNA) levels compared to healthy controls. This finding suggests cfDNA may be a biomarker in pediatric PD patients, though further research is needed.

Area of Science:

  • Pediatric Nephrology
  • Molecular Diagnostics
  • Biomarker Discovery

Background:

  • Cell-free DNA (cfDNA) is elevated in various conditions, including cancer and autoimmune disorders.
  • Previous studies noted increased cfDNA during hemodialysis, but data in pediatric peritoneal dialysis (PD) patients is limited.

Purpose of the Study:

  • To investigate plasma cell-free DNA (cfDNA) levels in children undergoing peritoneal dialysis (PD).

Main Methods:

  • Plasma cfDNA was quantified using real-time quantitative PCR for the beta-globin gene.
  • The study included 21 children on PD and 21 healthy children.

Main Results:

  • Children on PD exhibited significantly higher median plasma cfDNA concentrations (2,205 genome-equivalents/ml) than healthy controls (1,033 genome-equivalents/ml).
  • A significant positive correlation was found between C-reactive protein levels and plasma cfDNA concentrations in PD patients.

Conclusions:

  • This study is the first to demonstrate elevated cfDNA levels in children on PD treatment.
  • The underlying mechanisms and clinical significance of increased cfDNA in pediatric PD patients require further investigation.
Abstract

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...